| Leveraging multi-organ models for drug combination therapy safety | Biomedicine & pharmacotherapy |  | | 2025 | 39 | 94 |
|
| Microflow Liquid Chromatography Coupled to Multinozzle Electrospray Ionization for Improved Lipidomics Coverage of 3D Clear Cell Renal Cell Carcinoma | Analytical chemistry | | | 2025 | 52 | 56 |
|
| A cellular danse macabre: the choreography of programmed cell death | Apoptosis |  | | 2025 | 41 | 0 |
|
| Liposomal Tubacin: Strategies for the Formulation of a Highly Hydrophobic Anticancer Drug | Pharmaceutics | | | 2025 | 47 | 388 |
|
| Preclinical Photodynamic Therapy Targeting Blood Vessels withAGuIX® Theranostic Nanoparticles | Cancers | | | 2024 | 41 | 73 |
|
| Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology | Molecular therapy. Methods & clinical development | | | 2024 | 69 | 63 |
|
| Challenges in validation of combination treatment strategies for CRC using patient-derived organoids | Journal of experimental & clinical cancer research | | | 2024 | 47 | 80 |
|
| New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy | RSC medicinal chemistry | | | 2024 | 34 | 79 |
|
| Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization | Advanced science | | | 2024 | 38 | 224 |
|
| Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer | Cellular and molecular life sciences | | | 2023 | 130 | 389 |
|
| Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer | Oncoimmunology | | | 2023 | 249 | 129 |
|
| Advanced in vitro models for renal cell carcinoma therapy design | Biochimica et biophysica acta, CR. Reviews on cancer | | | 2023 | 101 | 266 |
|
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma | Journal of experimental & clinical cancer research | | | 2023 | 186 | 112 |
|
| Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy | Nature communications | | | 2022 | 190 | 129 |
|
| Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy | Angiogenesis | | | 2022 | 206 | 95 |
|
| FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells | Cancers | | | 2022 | 260 | 236 |
|
| Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets | Cancers | | | 2021 | 175 | 405 |
|
| Drug repurposing to identify a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma | Cancers | | | 2021 | 257 | 773 |
|
| A quarter century of Apoptosis | Apoptosis | | | 2021 | 226 | 1 |
|
| COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects | Angiogenesis | | | 2021 | 164 | 1 |
|
| Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomes | Nature reviews. Clinical oncology | | | 2021 | 410 | 5 |
|
| Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells | International journal of molecular sciences | | | 2021 | 209 | 423 |
|
| Forcing dividing cancer cells to die; low-dose drug combinations to prevent spindle pole clustering | Apoptosis | | | 2021 | 225 | 148 |
|
| Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) | European Journal of Heart Failure | | | 2020 | 241 | 350 |
|
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | | | 2020 | 449 | 204 |
|
| Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma | British Journal of Cancer | | | 2020 | 348 | 194 |
|
| Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment | Cancers | | | 2020 | 258 | 149 |
|
| Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance | Cancers | | | 2020 | 382 | 372 |
|
| Optimization for multidrug combinations: Challenges and perspectives in complex disorders | Pharmacological Research | | | 2020 | 396 | 4 |
|
| Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment | Molecules | | | 2020 | 391 | 362 |
|
| Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers | | | 2020 | 352 | 391 |
|
| Programmed death, cells on the last train to glory | Apoptosis | | | 2020 | 230 | 1 |
|
| Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression | British Journal of Cancer | | | 2019 | 465 | 241 |
|
| Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer | Biochimica et Biophysica Acta. Reviews on Cancer | | | 2019 | 498 | 1,701 |
|
| Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment | British Journal of Cancer | | | 2019 | 333 | 165 |
|
| Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering | Cancers | | | 2019 | 549 | 355 |
|
| Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib | Cancers | | | 2019 | 303 | 117 |
|
| Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma | Scientific Reports | | | 2019 | 454 | 283 |
|
| An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature | Vaccine | | | 2018 | 328 | 270 |
|
| Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth | The Journal of Pathology | | | 2018 | 273 | 179 |
|
| Apoptosis on the move | Apoptosis | | | 2018 | 252 | 151 |
|
| IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers | Angiogenesis | | | 2018 | 271 | 190 |
|
| Consensus guidelines for the use and interpretation of angiogenesis assays | Angiogenesis | | | 2018 | 845 | 1,019 |
|
| Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug | ChemMedChem | | | 2018 | 394 | 442 |
|
| Apoptosis turns 21 | Apoptosis | | | 2017 | 227 | 136 |
|
| Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment | Angiogenesis | | | 2017 | 308 | 522 |
|
| Angiogenesis inhibitors in combinatorial approaches | Angiogenesis | | | 2017 | 244 | 0 |
|
| Beyond mouse cancer models: Three-dimensional human-relevant in vitro and non-mammalian in vivo models for photodynamic therapy | Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis | | | 2017 | 217 | 0 |
|
| A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7) | Angiogenesis | | | 2017 | 291 | 160 |
|
| Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders | SLAS technology | | | 2017 | 254 | 5 |
|
| miRNAs: micro-managers of anticancer combination therapies | Angiogenesis | | | 2017 | 235 | 0 |
|
| Insulin-like growth factor axis targeting in cancer and tumour angiogenesis - the missing link | Biological Reviews | | | 2017 | 260 | 266 |
|
| Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity | Scientific Reports | | | 2017 | 298 | 198 |
|
